Total Payments
$249,551
2024 Payments
$5,335
Companies
32
Transactions
283
Medicare Patients
94
Medicare Billing
$10,488
Payment Breakdown by Category
Consulting$180,241 (72.2%)
Other$39,883 (16.0%)
Travel$21,490 (8.6%)
Food & Beverage$7,937 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $180,241 | 45 | 72.2% |
| Honoraria | $28,850 | 7 | 11.6% |
| Travel and Lodging | $21,490 | 65 | 8.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,033 | 7 | 4.4% |
| Food and Beverage | $7,937 | 159 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $63,228 | 67 | $0 (2019) |
| CSL Behring | $37,131 | 38 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $35,190 | 55 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $26,842 | 9 | $0 (2023) |
| Genentech USA, Inc. | $15,259 | 17 | $0 (2020) |
| Kedrion Biopharma Inc. | $13,305 | 9 | $0 (2019) |
| PFIZER INC. | $11,815 | 16 | $0 (2024) |
| Global Blood Therapeutics, Inc. | $10,414 | 3 | $0 (2021) |
| Dova Pharmaceuticals | $6,016 | 5 | $0 (2021) |
| Spark Therapeutics, Inc. | $5,165 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,335 | 9 | CSL Behring ($3,440) |
| 2023 | $10,404 | 18 | PFIZER INC. ($4,160) |
| 2022 | $13,583 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($10,323) |
| 2021 | $24,978 | 14 | Global Blood Therapeutics, Inc. ($10,414) |
| 2020 | $36,781 | 19 | Takeda Pharmaceuticals U.S.A., Inc. ($15,750) |
| 2019 | $43,141 | 62 | Shire North American Group Inc ($23,568) |
| 2018 | $60,165 | 67 | Shire North American Group Inc ($24,091) |
| 2017 | $55,164 | 80 | Shire North American Group Inc ($15,569) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 12/06/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $106.83 | General |
| 11/12/2024 | PFIZER INC. | HYMPAVZI (Drug) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Oncology | ||||||
| 07/30/2024 | CSL Behring | HEMGENIX (Biological) | Consulting Fee | Cash or cash equivalent | $3,440.00 | General |
| Category: Hematology | ||||||
| 03/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: HEMATOLOGY | ||||||
| 01/26/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: ONCOLOGY | ||||||
| 01/14/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: HEMATOLOGY | ||||||
| 12/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $60.12 | General |
| 10/13/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Oncology | ||||||
| 09/08/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug), LUTATHERA | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Oncology | ||||||
| 08/18/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.18 | General |
| 08/01/2023 | PFIZER INC. | XYNTHA (Biological), BENEFIX, COMIRNATY | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: HEMATOLOGY | ||||||
| 05/22/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: HEMATOLOGY | ||||||
| 05/16/2023 | PFIZER INC. | XYNTHA (Biological), BENEFIX, COMIRNATY | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: HEMATOLOGY | ||||||
| 04/10/2023 | BioMarin Pharmaceutical Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| 04/10/2023 | BioMarin Pharmaceutical Inc. | — | Travel and Lodging | In-kind items and services | $642.01 | General |
| 03/12/2023 | BioMarin Pharmaceutical Inc. | — | Travel and Lodging | In-kind items and services | $70.20 | General |
| 03/12/2023 | BioMarin Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 03/12/2023 | BioMarin Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $21.88 | General |
| 03/01/2023 | CSL Behring | Idelvion (Biological) | Consulting Fee | Cash or cash equivalent | $2,190.00 | General |
| Category: Hematology | ||||||
| 02/18/2023 | CSL Behring | Idelvion (Biological) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: Hematology | ||||||
| 02/17/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| 02/08/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 38 | $11,762 | $3,296 |
| 2022 | 3 | 44 | 56 | $17,904 | $5,070 |
| 2021 | 1 | 16 | 17 | $8,448 | $2,122 |
Total Patients
94
Total Services
111
Medicare Billing
$10,488
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 23 | $11,477 | $3,170 | 27.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 15 | $285.00 | $126.00 | 44.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 24 | $11,976 | $3,383 | 28.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 20 | $5,700 | $1,651 | 29.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 12 | $228.00 | $35.70 | 15.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 17 | $8,448 | $2,122 | 25.1% |
About Cindy Leissinger
Cindy Leissinger is a Specialist healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700839933.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cindy Leissinger has received a total of $249,551 in payments from pharmaceutical and medical device companies, with $5,335 received in 2024. These payments were reported across 283 transactions from 32 companies. The most common payment nature is "Consulting Fee" ($180,241).
As a Medicare-enrolled provider, Leissinger has provided services to 94 Medicare beneficiaries, totaling 111 services with total Medicare billing of $10,488. Data is available for 3 years (2021–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location New Orleans, LA
- Active Since 05/18/2006
- Last Updated 04/19/2017
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1700839933
Products in Payments
- ADVATE (Biological) $30,517
- Idelvion (Biological) $23,402
- ADYNOVATE (Biological) $14,658
- Jivi (Drug) $12,674
- HEMLIBRA (Biological) $12,626
- OXBRYTA (Drug) $10,469
- FEIBA (Biological) $9,064
- Koate (Biological) $8,098
- Non-Covered Product (Drug) $7,681
- Afstyla (Biological) $7,662
- Kovaltry (Drug) $7,326
- Non-Covered $7,245
- Doptelet (Drug) $6,016
- NovoSeven RT (Drug) $4,853
- HEMGENIX (Biological) $3,440
- NUWIQ (Biological) $3,418
- BENEFIX (Biological) $3,240
- KOATE (Biological) $2,600
- Koate (Drug) $2,500
- FERRIPROX (Drug) $2,100
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New Orleans
Dr. Fernando Sanchez, M.d, M.D
Specialist — Payments: $763,420
Specialist $763,420
Maissaa Janbain
Specialist — Payments: $684,013
Specialist $684,013
Dr. Keith Ferdinand, M.d, M.D
Specialist — Payments: $296,300
Specialist $296,300
Dr. William Smith, M.d, M.D
Specialist — Payments: $228,953
Specialist $228,953
Dr. Joia Crear-Perry, M.d, M.D
Specialist — Payments: $147,678
Specialist $147,678
Ms. Roberta Mcduffie, Cns, CNS
Specialist — Payments: $73,134
Specialist $73,134